Karam Butalia, the managing director of Merlion India and global head for private equity at Standard Chartered, has also been appointed as a director of Aurobindo. Citigroup acted as the exclusive arranger for this appointment by Aurobindo. |
"Aurobindo represents a key pharmaceutical sector investment for Merlion India. With its strong chemistry skills and cost-advantage, Aurobindo will soon be able to transform itself into a global generics player," said Karam Butalia. |